When human colon carcinoma cell lines were exposed to cisplatin, this treatment enhanced ICAM-1 and Fas (= CD95) expression, resulting in antigen-specific cytotoxic T-lymphocyte (CTL)-mediated lysis involving Fas-dependent and -independent mechanisms [32]. Here, FAS is linked to colon carcinoma.